Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Prostate Specific Antigen ELISA Kit

PSA Reaktivität: Human Colorimetric Sandwich ELISA 0-60 ng/mL Serum
Produktnummer ABIN996897
  • Target Alle Prostate Specific Antigen (PSA) ELISA Kits anzeigen
    Prostate Specific Antigen (PSA)
    Reaktivität
    • 14
    • 9
    • 7
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Nachweismethode
    Colorimetric
    Methodentyp
    Sandwich ELISA
    Detektionsbereich
    0-60 ng/mL
    Untere Nachweisgrenze
    0 ng/mL
    Applikation
    ELISA
    Verwendungszweck
    The PSA Enzyme Immunoassay test kit is intended for the quantitative determination of PSA in human serum.
    Proben
    Serum
    Analytische Methode
    Quantitative
    Spezifität
    98.7 %
    Sensitivität
    0.5 ng/mL
    Top Product
    Discover our top product PSA ELISA Kit
  • Probenmenge
    25 μL
    Testdauer
    1 h
    Plattentyp
    Pre-coated
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Lagerung
    4 °C
    Haltbarkeit
    12 months
  • Target Alle Prostate Specific Antigen (PSA) ELISA Kits anzeigen
    Prostate Specific Antigen (PSA)
    Andere Bezeichnung
    PSA (PSA Produkte)
    Hintergrund
    Human prostate-specific antigen (PSA) is a serine protease, a sigle chain glycoprotein with a molecular weight of approximately 34,000 daltons containing 7% carbohydrate by weight. PSA is immunologically specific for prostatic tissue, it is present in normal, benign hyperplastic, and malllignant prostatic tissue, in metastatic prostatic carcinoma, and also in prostatic fluid and seminal plasma. PSA is not present in any other normal tissue obtained from men, nor is it produced by cancers of the breast, lung, colon, rectum, stomach, pancreas or thyroid. Besides, it is functionally and immunologically different from prostatic acid phosphatase (PAP). Elevated serum PSA concentrations have been reported in patients with prostate cancer, benign prostatic hypertrophy, or inflammatory conditions of other adjacent genitourinary tissues, but not in apparently healthy men, men with non-prostatic carcinoma, apparently healthy women, or women with cancer. Reports have suggested that serum PSA is one of the most useful tumor markers in oncology. It may serves as an accurate marker for assessing response to treatment in patients with prostatic cancer. Therefore, measurement of serum PSA concentrations can be an important tool in monitoring patients with prostatic cancer and in determining the potential and actual effectiveness of surgery or other therapies. Recent studies also indicate that PSA measurements can enhancce early prostate cancer detection when combined with digital rectal examination (DRE).
    Pathways
    Komplementsystem
Sie sind hier:
Kundenservice